Table 2

Characteristics of anesthesia groups

MACTIVAVolComb
No of patients7123530
Men1 (14.3)5 (41.6)22 (62.8)18 (60)
Age, mean (SD)75.0 (11.4)69.8 (15.9)62.7 (17.2)66.5 (15.3)
Hypertension7 (100)11 (91.6)27 (77.1)27 (90)
Diabetes mellitus2 (28.5)5 (41.6)9 (25.7)7 (23.3)
Atrial fibrillation5 (71.4)7 (58.3)20 (57.1)17 (56.6)
Hyperlipidemia7 (100)9 (75)21 (60)22 (73.3)
Prior stroke/TIA1 (14.2)2 (16.6)4 (11.4)7 (23.3)
Coronary artery disease6 (85.7)9 (75)21 (60)21 (70)
NIHSS, median (IQR)18 (16–22)21.5 (16–26)19 (13–22)19 (14–23)
Proximal occlusion M14 (57.1)6 (50)19 (54.2)14 (46.6)
M2 occlusion2 (28.5)0 (0.0)8 (22.8)4 (13.3)
ICA occlusion1 (14.2)6 (50)8 (22.8)12 (40)
Mechanical thrombectomy5 (71.4)10 (83.3)30 (85.7)26 (86.6)
IA tPA07 (58.3)13 (37.1)10 (33.3)
Combination*05 (41.6)10 (28.5)9 (30)
ASA PS score <33 (42.9)4 (33.3)13 (37.1)14 (46.7)
Any vasopressor support1 (14.3)11 (91.7)31 (88.6)27 (90.0)
Good recovery (mRS 0–2)1 (14.3)3 (25)15 (42.9)3 (10)
  • Unless noted otherwise, data are N (%).

  • *Patients undergoing both mechanical thrombectomy and intra-arterial tPA. ASA PS, American Society of Anesthesiologists Physical Status; Comb, combined intravenous and volatile anesthesia; IA, intra-arterial; MAC, monitored anesthesia care; mRS, modified Rankin Scale; NIHSS, NIH stroke scale; TIA, transient ischemic attack; TIVA, total intravenous anesthesia; tPA, tissue plasminogen activator; Vol, volatile.